Business for Maggie Gyllenhaal’s The Bride!, starring Jessie Buckley and Christian Bale, is going from bad to worse in its second weekend at the box office. Written and directed by Gyllenhaal, The ...

Add Yahoo as a preferred source to see more of our stories on Google. Roche will no longer progress its anti-myostatin therapy Roche has halted plans to progress its anti-myostatin antibody, ...

Behind some of the viral physiques lies a troubling trend: the use of a powerful drug never approved for humans.

Metronidazole, sold under the brand name Flagyl, is an antibiotic and antiparasitic used to treat infections in the stomach, ...

Spain has the highest real GDP growth among major economies while Germany lags behind. Euronews Business takes a closer look at the figures, with experts explaining the key drivers. In 2025, the EU’s ...

Add Yahoo as a preferred source to see more of our stories on Google. Candace Owens’ “Bride of Charlie” has pulled millions of views on YouTube by packaging political grievance like serialized mystery ...

The rate of population growth in U.S. metro areas diminished nationwide in 2025, with those along the U.S.-Mexico border seeing the steepest dropoffs, according to the U.S. Census Bureau. The agency ...

Colleen Hoover is once again proving her box office prowess. Universal’s romantic drama “Reminders of Him,” the author’s latest best-seller to land on the big screen, impressed with $18.2 million from ...

What is the role of government in modern economies? Is it possible to create a more equal society without sacrificing economic freedom or wealth? Should we emphasize equal opportunities or equal ...

Dr. Shields is a physical therapist with a background in English Literature and a passion for healthcare and education. She hopes to combine her clinical expertise with her love of writing, establish ...

Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...

Roche has halted plans to progress its anti-myostatin antibody, emugrobart, to Phase III trials in spinal muscular atrophy (SMA) and facioscapulohumeral muscular dystrophy (FSHD). The Swiss pharma ...